Straits Times Index
3,314.05 +0.57 (+0.02%) S&P 500
5,313.14 +9.87 (+0.19%) Dow
39,862.75 -140.84 (-0.35%) Nasdaq
16,798.07 +112.11 (+0.67%) Bitcoin USD
68,706.28 +2,052.70 (+3.08%) CMC Crypto 200
1,384.54 +30.12 (+2.21%)
PFE Oct 2024 15.000 call
| Previous close | 13.95 |
| Open | 13.95 |
| Bid | 13.40 |
| Ask | 13.90 |
| Strike | 15.00 |
| Expiry date | 2024-10-18 |
| Day's range | 13.95 - 13.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 32 |
ZacksAstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
BenzingaEuropean Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte
ZacksPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
